Clobetasol Propionate Lotion recall due to manufacturing deviations
Teligent Pharma is recalling 35,180 bottles of Clobetasol Propionate Lotion 0.05% nationwide due to manufacturing deviations and discontinued stability testing. No illnesses reported.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class II voluntary precautionary recall with no reported illnesses or injuries. The recall stems from manufacturing deviations and discontinued stability testing rather than a confirmed hazard. Per the severity rubric, voluntary precautionary recalls are classified as Moderate.
Plain-English summary
Teligent Pharma, Inc. is recalling Clobetasol Propionate Lotion, 0.05%, in 2 fl. oz. (59 mL) and 4 fl. oz. (118 mL) bottles, totaling 35,180 units. The affected products were distributed nationwide in the USA and Puerto Rico.
The recall is due to current Good Manufacturing Practice (cGMP) deviations identified at the manufacturing facility. The firm is also discontinuing its stability study program, meaning it can no longer verify the product maintains its intended safety and effectiveness throughout its shelf life.
Consumers with this medication should contact their healthcare provider or pharmacist for guidance. Do not discontinue use without medical advice, as sudden cessation of prescribed topical corticosteroids may cause adverse effects.
The recalled product
- Product
- Clobetasol Propionate Lotion, 0.05%, packaged in a) 2 fl. oz. (59 mL) bottles, NDC 52565-055-02; b) 4 fl. oz. (118 mL) bottles, NDC 52565-055-04, Rx Only, Manufactured by: Teligent Pharma, Inc., Buena, New Jersey 08310.
- Manufacturer
- Teligent Pharma, Inc.
- Category
- Drug — Topical Corticosteroid
- Hazard
- Affected units
- 35,180
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (18)
- Batch: a) 15599
- Exp. 4/30/2022
- 16108
- Exp. 10/31/2022
- 16471
- Exp. 2/28/2023
- 16680
- Exp. 3/31/2023
- b) 15120
- 15126
- 15592
- Exp. 2/28/2022
- 15599
- 16145
- 16261
- Exp. 12/31/2022
- 16456
- 16552
Distribution
Part of a larger recall action
This product is one of 37 recalled by Teligent Pharma, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 37 products in this recall →Related recalls
Same manufacturer · Teligent Pharma, Inc.
See all →- ModerateDesonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Cream USP 0.1% Recall — Stability Study Discontinuation
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- HighDiflorasone Diacetate Ointment recalled due to discontinued stability studies
FDA (Drugs) · 2022-03-30
- ModerateClobetasol Propionate Cream USP 0.05% Recall for cGMP Deviations
FDA (Drugs) · 2022-03-30
Same hazard · manufacturing deviation
See all →- HighBaxter Recalls Vancomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateSynjardy XR Tablets Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2026-07-08
- ModerateDuloxetine delayed-release capsules recalled for N-nitroso impurity contamination
FDA (Drugs) · 2026-05-13
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
Similar recalls
- HighClobetasol Propionate Lotion Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2022-04-20
- LowTeligent Pharma Recalls Clobetasol Propionate Ointment Due to Potency Issues
FDA (Drugs) · 2020-12-09
- HighHalobetasol Propionate Ointment 0.05% Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2022-05-11
- ModerateBetamethasone Dipropionate Lotion recalled for failed stability test
FDA (Drugs) · 2022-01-05
- ModerateClobetasol Propionate Cream Recalled Due to CGMP Violations and Unverified Stability
FDA (Drugs) · 2023-06-07
- ModerateClobetasol Propionate Shampoo Recall Due to Manufacturing Compliance Issues
FDA (Drugs) · 2023-06-07